Redhill Biopharma Stock Price History

RDHL Stock  USD 6.74  0.34  5.31%   
Below is the normalized historical share price chart for Redhill Biopharma extending back to January 07, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Redhill Biopharma stands at 6.74, as last reported on the 21st of November, with the highest price reaching 6.79 and the lowest price hitting 6.37 during the day.
IPO Date
7th of January 2013
200 Day MA
10.5808
50 Day MA
8.5373
Beta
3.671
 
Yuan Drop
 
Covid
If you're considering investing in Redhill Stock, it is important to understand the factors that can impact its price. Redhill Biopharma maintains Sharpe Ratio (i.e., Efficiency) of -0.0705, which implies the firm had a -0.0705% return per unit of risk over the last 3 months. Redhill Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Redhill Biopharma's Risk Adjusted Performance of (0.03), coefficient of variation of (1,926), and Variance of 34.92 to confirm the risk estimate we provide.
  
At this time, Redhill Biopharma's Common Stock Shares Outstanding is quite stable compared to the past year. Common Stock is expected to rise to about 22.5 M this year, although the value of Total Stockholder Equity will most likely fall to about 2 M. . Price Earnings Ratio is expected to rise to 10.38 this year, although the value of Price To Sales Ratio will most likely fall to 34.49. Redhill Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0705

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRDHL

Estimated Market Risk

 4.84
  actual daily
43
57% of assets are more volatile

Expected Return

 -0.34
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Redhill Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Redhill Biopharma by adding Redhill Biopharma to a well-diversified portfolio.
Price Book
134.3516
Enterprise Value Ebitda
0.3005
Price Sales
2.2108
Shares Float
11.1 B
Wall Street Target Price
19 K

Redhill Biopharma Stock Price History Chart

There are several ways to analyze Redhill Stock price data. The simplest method is using a basic Redhill candlestick price chart, which shows Redhill Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 10, 202412.18
Lowest PriceNovember 20, 20246.4

Redhill Biopharma November 21, 2024 Stock Price Synopsis

Various analyses of Redhill Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Redhill Stock. It can be used to describe the percentage change in the price of Redhill Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Redhill Stock.
Redhill Biopharma Price Daily Balance Of Power 0.81 
Redhill Biopharma Accumulation Distribution 1,002 
Redhill Biopharma Price Action Indicator 0.33 
Redhill Biopharma Price Rate Of Daily Change 1.05 

Redhill Biopharma November 21, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Redhill Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Redhill Biopharma intraday prices and daily technical indicators to check the level of noise trading in Redhill Stock and then apply it to test your longer-term investment strategies against Redhill.

Redhill Stock Price History Data

The price series of Redhill Biopharma for the period between Fri, Aug 23, 2024 and Thu, Nov 21, 2024 has a statistical range of 5.78 with a coefficient of variation of 12.85. The price distribution for the period has arithmetic mean of 8.65. The median price for the last 90 days is 8.36. The company completed stock split (1:25) on 20th of August 2024.
OpenHighLowCloseVolume
11/21/2024 6.37  6.79  6.37  6.74  16,197 
11/20/2024 6.88  6.88  6.35  6.40  24,507 
11/19/2024 7.21  7.21  6.83  6.85  11,804 
11/18/2024 7.21  7.37  6.99  6.99  11,518 
11/15/2024 7.05  7.30  6.70  7.29  11,707 
11/14/2024 7.00  7.36  6.81  6.99  11,644 
11/13/2024 7.32  7.32  7.03  7.03  8,671 
11/12/2024 7.75  7.75  7.04  7.18  36,668 
11/11/2024 8.05  8.15  7.65  7.89  26,379 
11/08/2024 8.02  8.18  8.02  8.05  8,899 
11/07/2024 8.22  8.29  7.98  8.16  8,272 
11/06/2024 8.28  8.50  8.28  8.31  13,909 
11/05/2024 8.08  8.42  7.90  8.42  11,788 
11/04/2024 8.07  8.14  7.91  7.95  19,348 
11/01/2024 8.26  8.30  8.05  8.17  11,075 
10/31/2024 8.37  8.58  8.20  8.24  6,369 
10/30/2024 8.01  8.35  8.01  8.34  9,127 
10/29/2024 8.20  8.30  8.00  8.01  17,928 
10/28/2024 8.16  8.41  8.16  8.21  24,943 
10/25/2024 8.32  8.32  7.99  8.20  9,569 
10/24/2024 8.02  8.02  7.80  7.99  8,147 
10/23/2024 8.34  8.34  8.02  8.02  10,737 
10/22/2024 8.70  8.90  8.28  8.34  11,166 
10/21/2024 8.83  9.00  8.53  8.62  20,284 
10/18/2024 8.61  8.89  8.31  8.79  14,411 
10/17/2024 8.34  8.40  8.16  8.21  8,194 
10/16/2024 8.21  8.49  8.00  8.49  13,225 
10/15/2024 8.10  8.25  7.90  8.10  18,095 
10/14/2024 8.03  8.05  7.91  7.98  9,476 
10/11/2024 8.25  8.25  7.97  8.01  4,885 
10/10/2024 8.06  8.10  7.99  8.10  4,161 
10/09/2024 8.00  8.26  8.00  8.07  63,503 
10/08/2024 8.30  8.30  8.00  8.01  11,219 
10/07/2024 8.16  8.46  8.15  8.30  11,031 
10/04/2024 8.00  8.50  8.00  8.50  13,008 
10/03/2024 8.04  8.20  7.95  8.15  27,123 
10/02/2024 8.30  8.31  7.96  8.04  17,873 
10/01/2024 8.66  9.05  8.30  8.30  28,666 
09/30/2024 8.63  8.95  8.50  8.74  46,820 
09/27/2024 9.23  9.25  8.59  8.63  31,974 
09/26/2024 9.45  9.59  9.07  9.32  40,184 
09/25/2024 9.81  10.00  9.50  9.64  21,554 
09/24/2024 9.92  10.32  9.50  9.71  24,304 
09/23/2024 9.55  10.50  9.53  9.92  39,372 
09/20/2024 9.70  11.07  9.50  9.50  14,956 
09/19/2024 9.75  9.98  9.63  9.68  19,886 
09/18/2024 10.15  10.25  9.75  9.75  32,670 
09/17/2024 10.75  10.75  10.17  10.34  17,150 
09/16/2024 11.70  11.70  10.74  10.75  30,675 
09/13/2024 10.75  11.65  10.75  11.01  39,804 
09/12/2024 10.85  11.00  10.49  10.74  10,577 
09/11/2024 12.04  12.19  10.35  10.85  74,013 
09/10/2024 10.30  12.50  10.23  12.18  160,513 
09/09/2024 9.38  10.35  9.38  10.30  54,526 
09/06/2024 9.05  9.60  8.99  9.38  69,051 
09/05/2024 8.67  9.27  8.36  8.95  46,274 
09/04/2024 8.56  8.99  8.29  8.72  74,730 
09/03/2024 8.52  9.05  8.21  8.56  51,689 
08/30/2024 8.63  8.83  8.36  8.50  21,440 
08/29/2024 8.54  9.09  8.18  8.62  91,357 
08/28/2024 7.49  8.55  7.34  8.36  121,628 

About Redhill Biopharma Stock history

Redhill Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Redhill is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Redhill Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Redhill Biopharma stock prices may prove useful in developing a viable investing in Redhill Biopharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding6.5 M6.8 M
Net Loss-88 M-83.6 M

Redhill Biopharma Stock Technical Analysis

Redhill Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Redhill Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Redhill Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Redhill Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Redhill Biopharma's price direction in advance. Along with the technical and fundamental analysis of Redhill Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Redhill to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Redhill Biopharma is a strong investment it is important to analyze Redhill Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Redhill Biopharma's future performance. For an informed investment choice regarding Redhill Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Redhill Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(302.63)
Revenue Per Share
4.733
Quarterly Revenue Growth
(0.28)
Return On Assets
(0.45)
Return On Equity
(17.09)
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.